Copia Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42K Buy
35
+2
+6% +$2.04K 0.03% 228
2026
Q1
$30.4K Sell
33
-1
-3% -$1.01K 0.02% 240
2025
Q4
$36.5K Hold
34
0.03% 225
2025
Q3
$25.9K Hold
34
0.02% 247
2025
Q2
$26.5K Buy
34
+3
+10% +$2.33K 0.02% 215
2025
Q1
$25.6K Buy
31
+6
+24% +$4.99K 0.02% 205
2024
Q4
$19.3K Buy
+25
New +$20.7K 0.02% 215

Other funds holding LLY

Copia Wealth Management's LLY Position: Q2 2026 in Review

Copia Wealth Management increased its Eli Lilly (LLY) stake by 6.1% in Q2 2026, buying an estimated $2.04K and bringing the position to 35 shares worth $42K. The position accounts for 0.03% of the portfolio, ranked #228.

Copia Wealth Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Copia Wealth Management held 35 shares of Eli Lilly worth $42K as of Q2 2026.
  • Copia Wealth Management bought 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 0.03% of Copia Wealth Management's portfolio in Q2 2026, its #228 holding.
  • Copia Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Copia Wealth Management's 13F filing for Q2 2026, filed 18 Aug 2026.